Trial Profile
Association of Antibiotic Measures and Control of Bacterial Resistance
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Feb 2013
Price :
$35
*
At a glance
- Drugs Piperacillin/tazobactam (Primary)
- Indications Escherichia coli infections; Klebsiella infections; Methicillin-resistant Staphylococcus aureus infections; Nosocomial infections; Vancomycin-resistant enterococcal infections
- Focus Therapeutic Use
- Sponsors Wyeth
- 15 Feb 2013 New trial record